High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma

Abstract Objective Endometrial cancer patients may benefit from systemic adjuvant chemotherapy, alone or in combination with targeted therapies. Prognostic and predictive markers are needed, however, to identify patients amenable for these therapies. Methods Primary endometrial tumors were genotyped...

Full description

Saved in:
Bibliographic Details
Published inGynecologic oncology Vol. 128; no. 2; pp. 327 - 334
Main Authors Garcia-Dios, Diego A, Lambrechts, Diether, Coenegrachts, Lieve, Vandenput, Ingrid, Capoen, An, Webb, Penelope M, Ferguson, Kaltin, ANECS, Akslen, Lars A, Claes, Bart, Vergote, Ignace, Moerman, Philippe, Van Robays, Johan, Marcickiewicz, Janusz, Salvesen, Helga B, Spurdle, Amanda B, Amant, Frédéric
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2013
Subjects
Online AccessGet full text

Cover

Loading…